An interaction between glecaprevir, pibrentasvir, and colchicine causing rhabdomyolysis in a patient with chronic renal disease | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

An interaction between glecaprevir, pibrentasvir, and colchicine causing rhabdomyolysis in a patient with chronic renal disease

Harrison DS, Giang J, Darling JM. An interaction between glecaprevir, pibrentasvir, and colchicine causing rhabdomyolysis in a patient with chronic renal disease. Clin Liver Dis (Hoboken). 2020;15(1):17-20.

Publication Type:

Journal Article

Authors:

Harrison, DS; Giang, J; Darling, JM

Source:

Clin Liver Dis (Hoboken), Volume 15, Issue 1, p.17-20 (2020)

Cited On:

Patients with Renal Impairment

Export Citation:

RIS Format

Top